|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS (1) | ||||||||||||||||||||
| Real estate assets: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Real estate assets | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Real estate investment property, net, before developments in progress | ||||||||||||||||||||
| Net investment in real estate assets | ||||||||||||||||||||
| Held-for-sale | ||||||||||||||||||||
| Developments in progress | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Available-for-sale securities - at fair value (amortized cost of $290,311 and $292,646 as of September 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Tenant | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Investments in unconsolidated affiliates | ||||||||||||||||||||
| In-place leases, net | ||||||||||||||||||||
| Above market leases, net | ||||||||||||||||||||
| Intangible lease assets and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Mortgage and other indebtedness, net | ||||||||||||||||||||
| Below market leases, net | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Common stock, $.001 par value, 200,000,000 shares authorized, 30,940,789 and 30,322,052 issued and outstanding as of September 30, 2026 and December 31, 2025, respectively (in each case, excluding 34 treasury shares) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests and equity | ||||||||||||||||||||
Loading...